Antigen -Antibody Interactions Principles and Applications

MunazzaRashid6 10 views 70 slides Mar 03, 2025
Slide 1
Slide 1 of 70
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70

About This Presentation

Pathology


Slide Content

Autoimmune Disease Awareness Month News Briefing: The Status of Autoimmune Disease March 18, 2014 National Coalition of Autoimmune Patient Groups (NCAPG) 1

Agenda Bob Goldberg NCAPG, The National Coalition of Autoimmune Patient Groups ADAM, Autoimmune Disease Awareness Month Virginia Ladd What are Autoimmune Diseases? Stephanie Hales The NCAPG Accountable Care Act Survey Results Stanley Finger The need for Physician Education Aaron Abend The Autoimmune Disease Registry 2

National Coalition of Autoimmune Patient Groups (NCAPG) 3

National Coalition of Autoimmune Patient Groups (NCAPG)   Mission Statement To consolidate the voice of autoimmune disease patients and to promote increased education, awareness, and research into all aspects of autoimmune diseases through a collaborative approach. 4

NCAPG Members American Autoimmune Related Diseases Association American Behçet's Disease Association American Vitiligo Research Foundation APS Foundation of America Arthritis Foundation Celiac Disease Foundation Celiac Sprue Association Coalition for Pulmonary Fibrosis Crohn's and Colitis Foundation of America Dysatonomia International Endometriosis Association Gluten Intolerance Group Graves’ Disease Foundation International Foundation for Autoimmune Arthritis International Pemphigus & Pemphigoid Foundation Lupus Foundation of America 5

NCAPG Members Lupus Foundation of Mid and Northern New York Myasthenia Gravis Foundation of America National Adrenal Diseases Foundation National Alopecia Areata Foundation National Kidney Foundation National Multiple Sclerosis Society National Psoriasis Foundation National Sleep Foundation P.A.N.D.A.S. Network.org Platelet Disorder Support Association Scleroderma Foundation Sjögren's Syndrome Foundation The Myositis Association Transverse Myelitis Association U.S. Pain Foundation Vasculitis Foundation Vitiligo Support International 6

March is Autoimmune Disease Awareness Month Unmet needs impacting on autoimmune patients Affordable Care Act (ACA) Delayed diagnosis Physician education Awareness No multiple specialty center of excellence No autoimmune disease registry 7

Thank you! 8

What are Autoimmune Diseases? 9

Autoimmune diseases are the result of a misdirected immune system that causes one’s own immune system to attack the self 10

Autoimmunity at a Glance Over 100 diseases Affecting 50 million Americans Costing over $120 billion annually 250,000 new diagnoses each year A major cause of death in women 11

Autoimmune disease can affect any part of the body 12

13

Thank you! 14

ACA Survey National Coalition of Autoimmune Patient Groups (NCAPG) 15

Framing Thoughts Overview of this survey and why NCAPG conducted it The power and importance of advocacy 16

Age & Sex of Survey Respondents Reflects the disproportionate impact of autoimmunity on women 17

What conditions were you diagnosed with? Disease # Respondents Addison's Disease 97 Hashimoto's disease 32 Rheumatoid arthritis 23 Crohn's disease 22 Fibromyalgia 19 Sjogren's Disease 19 Lupus (SLE) 18 Graves' disease 12 Ulcerative Colitis 11 Autoimmune thyroid disease 9 Other AD 95 No Response 81 Non AD 43 18

Were you insured prior to the ACA? 19

If you were uninsured prior to the ACA, was it due to having a preexisting condition or being unable to afford a premium? 20

If you were previously uninsured, were you able to enroll in the ACA? 21

When the ACA became effective, did you have to select a new plan? 22

Has your premium increased? 23

Has your deductible increased, decreased or remained about the same after enrolling in the ACA? 24

Has your coverage increased, decreased or remained the same in the services important to you? 25

Has the price of your prescriptions increased, decreased or remained the same? 26

Were you able to keep the same prescriptions that you had prior to the ACA? 27

Have you suffered adverse reactions due to drug changes? 28

Were you able to keep the same specialists through the ACA? 29

Do you have concerns about the accessibility of specialists under the ACA? 30

Were you better off before or after the ACA? 31

Responses Reflect Some Improvements, but a Strong Need for Continued Advocacy “I believe the ACA is a step in the right direction. Improvements are necessary, for instance out of network options.” “I love ACA. I am now getting the help and medications I needed, plus test confirms ... not [rheumatoid arthritis] as first suspected ... [mixed connective tissue disease].” “[M]y employer had to change or insurance provider. Now I pay higher premiums, higher copays, and three of my specialists are no longer on our new plan.” “I was adversely affected when my former employer switched to a high deductible [health plan] when anticipating the premium jump ACA would cause.” 32

Thank you! 33

AARDA Autoimmune Disease Diagnosis Surveys 34

AD Diagnosis Takes an Inordinate Amount of Time and Perseverance Survey Issues 1996 2001 2006 2013 Years to Diagnosis 5 4 4 4 No. Physicians Seen 6 4 4 5 Labeled Chronic Complainer 64% 45% 45% 51% 35

Years to Diagnosis 36

Number of Doctors Seen to get a Diagnosis 37

Percent told their disease was imagined or they were overly concerned … 38

Why so Long and Difficult to Get a Correct Diagnosis? Physician Education was identified as a contributing factor. 39

AARDA Conducted a Survey of Physicians AARDA participated in an educational workshop attended by 130 family physicians. Participants were asked to participate in a survey on the extent of their knowledge of autoimmune diseases. The survey results prompted a larger ongoing study. 40

In medical school, how much training in autoimmune diseases did you receive? 41

Would you agree that you received enough training to diagnose and treat autoimmune disease? 42

What is your level of comfort in diagnosing autoimmune disease? 43

Strategic Goal AARDA is conducting a larger study to determine: Level of physician education Physicians’ preferred way of continuing education With the goal of developing A syllabus for medical school A Continuing Medical Education program for autoimmune diseases 44

Public Awareness also contributes to the problem Awareness Study GFK randomly surveyed 1000 Americans Study is conducted every five to seven Years to measure progress 45

Public Awareness of Autoimmune Diseases 1992 2001 2008 2013 Correctly name an autoimmune disease 5% 6% 13% 15% Thought AIDS was an autoimmune disease 93% 38% 32% 21% 46

Need for a Multiple Specialist Center of Excellence for Diagnosing and Treating Autoimmune Diseases A patient Survey Would you travel to a center to get diagnosed ? Yes - 75% No - 25% 47

Travel to a Center for: (may select more than one) Second opinion 69.7% Specialized treatment 86.5% Coordinated care 76.9% 48

Improved Autoimmune Disease Diagnosis Requires Increased Physician education Increased Public Awareness Autoimmune Disease Multi-Specialist Center 49

Return on Investment Fewer chronic disabilities Less human suffering Dramatic reduction in AD healthcare costs 50

Thank you! 51

The Autoimmune Disease Registry 52

In the US today, there are 13,027,914 individuals with cancer How many have autoimmune disease? 9 million? 23 million? 50 million? 53

What is goal of the Autoimmune Disease Registry? A system that can count every patient suffering from an autoimmune disease. It will encompass data already collected by individual disease registries, but it will not supplant those registries It will be used for: Research - for cohort discovery and some population research Public health reporting It will not be used for: Fundraising Patient treatment It will be the SEER system for Autoimmune Disease 54

What do SEER & NAACCR do for Cancer? Surveillance , Epidemiology, and End Results Program (SEER) The premier source for cancer statistics in the United States; Provides information on cancer statistics in an effort to reduce the burden of cancer among the U.S. population. The North American Association of Central Cancer Registries A professional organization that develops and promotes uniform data standards for cancer registration Provides education and training; Certifies population-based registries; Aggregates and publishes data from central cancer registries; Promotes the use of cancer surveillance data and systems for cancer control and epidemiologic research, public health programs, and patient care to reduce the burden of cancer in North America. 55

56

57

58

59

60

61

62

63

64

65

The ADR can accomplish the following Provide a central resource for recruitment of patients for clinical trials; Provide statistics on the burden of AD on public health; Provide statistics on multiple-disease sufferers; Provide consolidated statistics that can transform the image of AD as a large number of unrelated and mostly rare diseases to something similar to Cancer – a single disease with a variety of sometimes common, sometimes rare manifestations . 66

Proposed Milestones Short Term Take results from the current survey and put them into a database for ad hoc query by NCAPG members; Establish data standards for AD similar to those established by NAACCR for Cancer; Provide support to NCAPG members to make their own data accessible to researchers and prepare it for participation in a national network (including addressing the patient consent necessary to accomplish this goal); Long Term Establish protocols for research using the ADR, including an IRB and an Honest Broker (an individual tasked with distributing data pursuant to IRB authorization); Develop a reporting website like SEER for AD (see http://seer.cancer.gov/data/ ) Identify sources of ongoing funding for the ADR and submit proposals to promising sources . 67

Next Steps Establish a governing process for NCAPG oversight and control of the registry Establish protocols for data handling and use Begin to aggregate de-identified NCAPG data Create a central query resource for de-identified AD Data Engage with NIH and others to bring all AD under a single umbrella, like Cancer 68

Thank you! 69

Autoimmune Disease Awareness Month News Briefing: The Status of Autoimmune Disease March 18, 2014 National Coalition of Autoimmune Patient Groups (NCAPG) 70
Tags